ABC-TC3576

Human Cord Blood CD34+ Progenitor Cells, Pooled

CD34 is a well-known marker for primitive and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial progenitors. Gentaur offers CD34+ progenitor cells in a phenotypically undifferentiated state. The progenitor cells are derived from cord blood of healthy donors and produced at the Gentaur facility. Progenitor cells contain two main cellular subpopulations, hematopoietic and endothelial progenitor cells. CD34+ progenitor cells are suitable for a series of studies for directed differentiation into more committed types of blood cells and endothelial lineages. Immediately after isolation, the freshly prepared CD34+ progenitor cells are cryopreserved using a serum-free freezing medium.Samples from each donor are tested via PCR to confirm non-reactivity.Cord blood CD133+ cells are isolated using direct positive immunomagnetic selection for CD133+ cells. The majority of CD133+ cells also express CD34. CD133 is a glycoprotein with sub-cellular localization in plasma membrane protrusions. In humans, this protein was originally identified as an antigenic marker expressed on hematopoietic stem cells. In addition, these cells are highly proliferative primitive hematopoietic progenitors. They can give rise to mature terminally differentiated hematopoietic cells by means of directed differentiation.Gentaur offers CD133 cells in a phenotypically undifferentiated state. The cells are derived from fresh cord blood of healthy donors and produced at the Gentaur facility. Immediately after isolation, the freshly prepared CD133 cells are cryopreserved using a serum-based cryopreservation medium. Each vial contains 100,000 cells per vial.

Ask for quotation

ABC-TC3560

Human CD34+ Umbilical Cord Blood Cells, Pooled

Human CD34+ umbilical cord blood cells are isolated from umbilical cord blood and purified using magnetic cell separation. Human CD34+ umbilical cord blood cells are from a single donor and are 90% pure populations as confirmed by FACS analysis. These cells are regularly used to reconstitute the hematopoietic system in infants and small children with malignancies. These cells also enable researchers to produce various cell types using standard published protocols. Additionally, CD34+ umbilical cord blood cells may be used for various studies on hematopoiesis, differentiation, angiogenesis, colony formation, and surface marker expression. Presently, they are widely investigated for various therapeutic applications. Development period: Postnatal

Ask for quotation

CBCD34-C0.5M

Human Cord Blood CD34+ Stem / Progenitor Cells

2467 €

ABC-SC0083T

HighQC™ Human Cord Blood CD34+ Stem Cell (CD34-Depleted MNC)

CD34 is a glycosylated transmembrane protein and represents a well-known marker for primitive blood-and bone marrow-derived progenitor cells, especially for hematopoietic and endothelial stem cells. CD34+ stem cells are multipotent and can differentiate to all hematopoietic cell types in blood. CD34+ cells can also give rise to all lymphohematopoietic lineages even though they comprise only a small percentage of the cell population. Our CD34+ cells are isolated using positive immunomagnetic cell separation procedures from single or mixed healthy donors. All cord blood is collected in Citric Phosphate with Dextrose Buffer (CPD) from fully consented IRB approved donors.

Ask for quotation

ABC-TC3376

Human Cord Blood CD4+ Helper T Cells

Cord Blood CD4+ Helper T cells are negatively isolated from mononuclear cells using an indirect immunomagnetic CD4+ T cell labeling system to deplete the non-CD4+ cells.

Ask for quotation

ABC-TC3379

Human Cord Blood CD8+ Cytotoxic T Cells

Cord Blood-CD8+ Cytotoxic T cells are negatively isolated from mononuclear cells, using an indirect immunomagnetic CD8 labeling system to deplete the non-CD8+ cells.

Ask for quotation